BioSkryb Genomics, a Durham developer of amplification tools for single-cell analysis, has signed an agreement with a Dutch company to expand distribution of BioSkryb’s genomic and multiomic technology in Europe. Here are the details.
Read More
BioSkryb is launching a grant program to secure a “breakthrough” in single-cell genomics using its proprietary technology, recently launched commercially as ResolveDNA.
Read More
BioSkryb, an emerging genetics startup in Durham, is gearing up to commercialize its proprietary technology after landing $11.5 million in an initial round of venture funding.
Read More
